Abstract:Nanomedicines have achieved several successful clinical applications for cancer therapy over the past decades. To date, numerous nanomedicine formats and design rationales have been proposed to improve pharmaceutical delivery and treatment efficacy. Despite these advances, the achievement of high drug loading and loading efficiencies of drug payloads in nanocarriers remains a technical challenge. In addition, study of the correlation between therapeutic potential and drug loading has been ignored. Here, using a self-assembling dimeric cabazitaxel prodrug, we show that the prodrug can be quantitatively entrapped within clinically approved polymer matrices for intravenous injection and that the drug loading in the nanoparticles (NPs) is tunable. The engineered NPs (NPs1-4) with different drug loading values exhibit dissimilar morphologies, release kinetics, in vitro cytotoxic activity, pharmacokinetic properties, tissue distribution, and in vivo anticancer efficacy and safety profiles. Furthermore, the effect of drug loading on the treatment outcomes was explored through detailed in vitro and in vivo studies. Intriguingly, among the constructed NPs, those comprising poly(ethylene glycol)-block-poly(D,L-lactic acid) (PEG-PLA) copolymers showed substantially prolonged pharmacokinetic properties in the blood circulation, which further promoted their intratumoral delivery and accumulation. Furthermore, the PEG-PLA-composed NPs with high drug loading (~50%) demonstrated favorable efficacy and safety profile in animal models. These data provide convincing evidence that the in vivo performance of a given self-assembling drug is not compromised by high drug loading in nanoplatforms, which may potentially reduce concerns over excipient-associated side effects and immunotoxicities. Overall, our study provides new insight into the rationale for designing more effective and less toxic delivery systems.

Nanodiamond Therapeutic Delivery Agents Mediate Enhanced Chemoresistant Tumor Treatment

Nanodiamond in Cancer Theranostics

Nanodiamonds: Next generation nano-theranostics for cancer therapy

Synthesis of nanodiamond-daunorubicin conjugates to overcome multidrug chemoresistance in leukemia

Nanodelivery of a Self-Assembling Prodrug with Exceptionally High Drug Loading Potentiates Chemotherapy Efficacy.

Enhanced penetrative siRNA delivery by a nanodiamond drug delivery platform against hepatocellular carcinoma 3D models

Nanodiamond Effects on Cancer Cell Radiosensitivity: The Interplay between Their Chemical/Physical Characteristics and the Irradiation Energy

Co-delivery of paclitaxel and cetuximab by nanodiamond enhances mitotic catastrophe and tumor inhibition

Nanodiamond-based photosensitizer: Enhancing photodynamic therapy and inhibiting tumor metastasis

Nanomaterials in Cancer-Therapy Drug Delivery System

PolyPEGylated Nanodiamond for Intracellular Delivery of a Chemotherapeutic Drug

Targeted therapeutic nanotubes influence the viscoelasticity of cancer cells to overcome drug resistance

Better together: nanoscale co-delivery systems of therapeutic agents for high-performance cancer therapy

Nanotherapeutic approaches to overcome distinct drug resistance barriers in models of breast cancer

Anticancer Drug Nanomicelles Formed By Self-Assembling Amphiphilic Dendrimer To Combat Cancer Drug Resistance

Synthesis and Characterization of Nanodiamond-Doxorubicin (Dox) Conjugate for Effective Delivery against MCF-7 Cell Lines

A short appraisal of nanodiamonds in drug delivery and targeting: recent advancements

Nanodelivery Systems as a Novel Strategy to Overcome Treatment Failure of Cancer

Exploring nanodiamonds: leveraging their dual capacities for anticancer photothermal therapy and temperature sensing

Drug Nanocrystals for Active Tumor-Targeted Drug Delivery

Chemoradiotherapy and nanomedicine: Drug mechanisms and delivery systems